MegaPro Biomedical Co (ROCO:6827) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6827 MegaPro Biomedical Co Ltd ROCO:6827
33 GF Score
Price NT$10.70
View Full Analysis

What is MegaPro Biomedical Co FCF Margin %?

MegaPro Biomedical Co ROCO:6827 -2.28% 33 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:6827 with a GF Score™ of 33/100. Among 950 Biotechnology companies, MegaPro Biomedical Co ranks worse than 105263.05% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. MegaPro Biomedical Co's Free Cash Flow for the six months ended in Dec. 2025 was NT$-66.94 Mil. MegaPro Biomedical Co's Revenue for the six months ended in Dec. 2025 was NT$0.00 Mil. Therefore, MegaPro Biomedical Co's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, MegaPro Biomedical Co's current FCF Yield % is -13.75%.

The historical rank and industry rank for MegaPro Biomedical Co's FCF Margin % or its related term are showing as below:


During the past 8 years, the highest FCF Margin % of MegaPro Biomedical Co was -2205.09%. The lowest was -1038121.43%. And the median was -578255.56%.

ROCO:6827's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -81.28
* Ranked among companies with meaningful FCF Margin % only.

MegaPro Biomedical Co FCF Margin % Related Terms

MegaPro Biomedical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for MegaPro Biomedical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MegaPro Biomedical Co FCF Margin % Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -578,255.56 -1,038,121.43 0.00

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -297,605.56 -513,378.57 0.00 0.00 0.00

ROCO:6827 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, MegaPro Biomedical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MegaPro Biomedical Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MegaPro Biomedical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where MegaPro Biomedical Co's FCF Margin % falls into.


ROCO:6827
33GF Score
MegaPro Biomedical Co Ltd ROCO:6827
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MegaPro Biomedical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

MegaPro Biomedical Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-116.783/0
= %

MegaPro Biomedical Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-66.941/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
MegaPro Biomedical Co (ROCO:6827) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on MegaPro Biomedical Co and its competitors. According to the industry distribution chart, MegaPro Biomedical Co ranks #999999 out of 950 companies in the Biotechnology industry.
Is MegaPro Biomedical Co's FCF Margin % too high?
MegaPro Biomedical Co's current FCF Margin % is 0.00%. Based on the distribution chart, MegaPro Biomedical Co ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MegaPro Biomedical Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does MegaPro Biomedical Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MegaPro Biomedical Co ranks #999999 out of 950 companies for FCF Margin %. This places MegaPro Biomedical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on MegaPro Biomedical Co and its competitors. MegaPro Biomedical Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MegaPro Biomedical Co stock overvalued right now?
MegaPro Biomedical Co (ROCO:6827) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. MegaPro Biomedical Co's overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For MegaPro Biomedical Co (ROCO:6827), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MegaPro Biomedical Co Business Description

Address No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.
33GF Score

Get the complete analysis for ROCO:6827

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.70
Price